EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort

Laura Wagner iD, Milena Wurst, Johanna Erber, Tobias Bachfischer, Bernhard Haller, Sabine Gleich, Karl Dichtl, Roland M Schmid, Julian Triebelhorn, Florian Voit, Ulrich Seybold, Dirk H Busch und 4 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00052-25 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Laura Wagner und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Enterococcus faecium, Gram-Positive Bacterial Infections, Bacteremia, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterococcus faecium is difficult to treat owing to its intrinsic and acquired resistance to antibiotics, particularly vancomycin. Vancomycin-resistant Enterococcus faecium is an important cause of bloodstream infections in healthcare settings with limited treatment options. This study aimed to analyze the risk factors for vancomycin-resistant Enterococcus faecium bloodstream infection. This retrospective analysis of data from the Munich Multicentric Enterococci Cohort analyzed 200 episodes of nonrecurrent vancomycin-susceptible Enterococcus faecium bloodstream infection and 196 episodes of nonrecurrent vancomycin-resistant Enterococcus faecium bloodstream infection from six hospitals in Munich, Germany, between 2010 and 2019. Logistic regression was used to identify risk factors for vancomycin-resistant Enterococcus faecium bloodstream infection. In the unadjusted analysis, the risk factors for vancomycin-resistant Enterococcus faecium bloodstream infection included the length of hospital stay, previous treatment with vancomycin or linezolid, and solid organ transplantation. In the multivariable analysis, prior treatment with vancomycin and solid organ transplantation were independent risk factors for vancomycin-resistant Enterococcus faecium bloodstream infection. Vancomycin resistance was not significantly associated with the severity of underlying diseases. This study identified prior vancomycin treatment and solid organ transplantation as key independent risk factors for vancomycin-resistant Enterococcus faecium bloodstream infection. IMPORTANCE Vancomycin-resistant Enterococcus faecium is a growing threat in healthcare settings, challenging the management of enterococcal infections. This study identified prior treatment with vancomycin and solid organ transplantation as risk factors for vancomycin-resistant Enterococcus faecium bloodstream infections. Based on the analysis of five disease severity scores for acute and chronic illness, the severity of underlying diseases could not be demonstrated to be a risk factor for the occurrence of vancomycin resistance in Enterococcus faecium bloodstream infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterococcus faeciumGram-Positive Bacterial InfectionsBacteremiaVancomycin-Resistant EnterococciVancomycin ResistanceHumansRisk FactorsRetrospective StudiesMaleFemaleMiddle AgedAnti-Bacterial AgentsAgedVancomycinGermanyAdultAged, 80 and overLinezolid

Stichwörter der Autor:innen

EnterococcusEnterococcus faeciumantibiotic resistancebloodstream infectionsvancomycin resistance

Substanzen

Anti-Bacterial AgentsVancomycinLinezolid

Autor:innen und Institutionen

  • Department of Internal Medicine II, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany.
  • German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.
  • Institute of AI and Informatics in Medicine, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Public Health Service, City of Munich, Munich, Germany.
  • Max von Pettenkofer Institute for Hygiene und Medical Microbiology, Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany.
  • Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.

ORCID-Profile: Laura Wagner

Zitieren

APA

Wagner, L., Wurst, M., Erber, J., Bachfischer, T., Haller, B., Gleich, S., Dichtl, K., Schmid, R. M., Triebelhorn, J., Voit, F., Seybold, U., Busch, D. H., Rämer, P. C., Spinner, C. D., Schneider, J., & Rothe, K. (2025). Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00052-25

Vancouver

Wagner L, Wurst M, Erber J, Bachfischer T, Haller B, Gleich S, et al. Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00052-25

BibTeX
@article{Wagner2025,
  author = {Wagner, Laura and Wurst, Milena and Erber, Johanna and Bachfischer, Tobias and Haller, Bernhard and Gleich, Sabine and Dichtl, Karl and Schmid, Roland M and Triebelhorn, Julian and Voit, Florian and Seybold, Ulrich and Busch, Dirk H and Rämer, Patrick C and Spinner, Christoph D and Schneider, Jochen and Rothe, Kathrin},
  title = {Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00052-25}
}
Kostenlos starten →